Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07739290
NA

NAD Supplementation to Reduce the Incidence of Cardiac Surgery Associated Acute Kidney Injury

Sponsor: Beth Israel Deaconess Medical Center

View on ClinicalTrials.gov

Summary

The purpose of this single-center, randomized, double-blinded placebo-controlled pilot trial is to demonstrate feasibility and help design a larger trial to assess the effectiveness of nicotinamide (NAM) supplementation in reducing risk of post-operative AKI in patients undergoing cardiac surgery.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2026-09-01

Completion Date

2029-01-01

Last Updated

2026-07-31

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Nicotinamide (NAM)

A one time 3000 mg nicotinamide dose administered orally on the morning of cardiac surgery

DIETARY_SUPPLEMENT

Placebo control

A visually identically placebo